AltPep
PrivateLast Round
Series B
Jun 22, 2023
Total Funding Raised
$120.45M
Company Overview
AltPep is a biotechnology company that operates a proprietary peptide-based platform designed to diagnose and neutralize toxic precursors to amyloid diseases, offering innovative solutions for early detection and treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AltPep Comps
Public and private peers based on sector, stage, and business model.
AltPep Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 22, 2023 | ||||
| Series B | Jul 26, 2022 | ||||
| Series A | Jan 14, 2021 |
Key People
Founding team and executive leadership
AltPep Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series B |
| Senator Investment Group | Series B |
| Alexandria Venture Investments | Series B, Series A |
| Matrix Capital Management | Series B, Series A |
| Partners Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2025
New preclinical data for SOBIN-AD showed improved behavior in disease models.
- Dec 1, 2025
Presented at the CTAD 2025 conference on December 1, 2025.
AltPep Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AltPep's valuation, stock price, and market status.
